0.656
-0.16 (-20.02%)
| Penutupan Terdahulu | 0.820 |
| Buka | 0.780 |
| Jumlah Dagangan | 13,516,256 |
| Purata Dagangan (3B) | 5,164,330 |
| Modal Pasaran | 185,906,176 |
| Harga / Jualan (P/S) | 2.93 |
| Harga / Buku (P/B) | 8.28 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 7 May 2025 - 12 May 2025 |
| Margin Keuntungan | -169.45% |
| Margin Operasi (TTM) | -342.87% |
| EPS Cair (TTM) | -0.490 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 269.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 134.24% |
| Nisbah Semasa (MRQ) | 1.13 |
| Aliran Tunai Operasi (OCF TTM) | -67.14 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -38.09 M |
| Pulangan Atas Aset (ROA TTM) | -46.05% |
| Pulangan Atas Ekuiti (ROE TTM) | -185.39% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Sangamo Therapeutics, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 0.75 |
|
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington’s Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 2.17% |
| % Dimiliki oleh Institusi | 27.49% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 10.00 (HC Wainwright & Co., 1,424.86%) | Beli |
| Median | 5.00 (662.43%) | |
| Rendah | 2.00 (RBC Capital, 204.97%) | Pegang |
| Purata | 5.67 (764.59%) | |
| Jumlah | 2 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 0.899 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 07 Apr 2025 | 10.00 (1,424.86%) | Beli | 0.656 |
| 27 Jan 2025 | 10.00 (1,424.86%) | Beli | 1.13 | |
| RBC Capital | 18 Mar 2025 | 2.00 (204.97%) | Pegang | 0.850 |
| Truist Securities | 23 Jan 2025 | 5.00 (662.43%) | Beli | 1.19 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |